Diagnosis and treatment of coronary artery disease in patients with chronic kidney disease

Heart

Volumn 94, Issue 8, 2008, Pages 1080-1088

  Johnston, Nicola ^a   Dargie, Henry ^b   Jardine, Alan ^c  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; EZETIMIBE PLUS SIMVASTATIN; FIBRINOGEN RECEPTOR ANTAGONIST; GADOLINIUM; GEMFIBROZIL; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ACUTE CORONARY SYNDROME; BLEEDING; BLOOD CLOT LYSIS; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; PERCUTANEOUS CORONARY INTERVENTION; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; RISK REDUCTION; SCREENING; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION; SYSTOLIC DYSFUNCTION;

ALGORITHMS; CORONARY ARTERY DISEASE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MYOCARDIAL INFARCTION; PREOPERATIVE CARE;

EID: 47849105011     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.136739     Document Type: Review

References (22)

1. Parfrey PS, Foley RN, Sarnark MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998(suppl 3):S112-19. ▶ Original article describing the incremental cardiovascular risk associated with all stages of CKD.
2. US Renal Data System. 1998 Annual Data Report. Bethesda National Institutes of Health, National Institute of Diabetes and Kidney Diseases, 1998.
3. Jungers P, Massey ZA, Khoa TN, et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant 1997;12:2597-602.
4. Thygesen K, Alpert JS, White HD on behalf of the Joint ESC/ACCF/AHA/WHF Taskforce for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525-38.
5. Herzog CA, Ma JZ, Collins AJ. Poor long term survival after acute myocardial infarction among patients on long term dialysis. N Engl J Med 1998;339:799-805.
6. Herzog CA, Littrell K, Arko C, et al. Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction. Circulation 2007;116:1465-72. ▶ Trial demonstrating atypical presentation of acute myocardial infarction in patients on renal replacement therapy and associated lower rate of receiving reperfusion therapy.
7. Wright RS, Reeder GS, Herzog CA, et al. Acute myocardial infarction and renal dysfunction: a high risk combination. Ann Intern Med 2002;137:563-70. ▶ Observational study describing "therapeutic nihilism" regarding the prescription of secondary preventative medical therapy in patients with CKD post-AMI.
8. Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients receiving thrombolytic therapy for acute myocardial infarction in the US. Circulation 1999:100(Suppl I):I-304.
9. Keeley EC, Kadakia R, Soman S, et al. Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 2004;92:509-14. ▶ Study demonstrating a survival benefit of coronary revascularisation post-ACS in patients with advanced CKD compared to medical treatment.
10. Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting and coronary artery bypass surgery and impact of diabetes. Circulation 2002;106:2207-11. ▶ Evidence of long term benefit of CABG versus PCI or medical treatment in patients with ESRF and stable multi-vessel CAD.
11. Reddan DN, O'Shea JC, Sarembock IJ, et al. Treatment effects of eptifibatide in planned coronary artery stent implantation in patients with chronic kidney disease. Am J Cardiol 2003;91:17-21.
12. Chew DP, Lincoff AM, Gurm H, et al for the REPLACE-2 Investigators. Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 Trial. Am J Cardiol 2005;95:581-5.
13. Jaber W, DiFilippo FP, Cerqueira M. Left ventricular hypertrophy and SPECT myocardial perfusion imaging: finding diamonds in the rough. J Nucl Cardiol 2007;14:398-407.
14. Sharma R, Pellerin D, Gaze D, et al. Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol Dial Transplant 2005;20:2207-14. ▶ Recent study showing accurate non-invasive prediction of obstructive CAD using DSE in patients with ESRF undergoing assessment for renal transplantation.
15. Mark PB, Johnston N, Groenning BA, et al. Redefinition of uraemic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int 2006;69:1839-45. ▶ Demonstration of close relationship of previous AMI and LVSD in patients undergoing assessment for renal transplantation using CMR.
16. Sharples EJ, Pereira D, Summers S, et al. Coronary artery calcification measured with electron-beam computed tomography correlates poorly with coronary angiography in dialysis patients. Am J Kidney Dis 2004;43:313-19. ▶ Early CT study showing very high coronary calcium burden in patients with ESRF and poor correlation with obstructive disease at coronary angiography.
17. Wanner C, Krane V, Marz W, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing haemodialysis. N Engl J Med 2005;353:238-48.
18. Cice G, Ferrara L, D'Andrea A, et al. Carvedilol increases the two-year survival in dialysis patients with dilated cardiomyopathy: a prospective placebo controlled trial. J Am Coll Cardiol 2003;41:1438-44. ▶ Evidence that the prescription of carvedilol in patients with ESRF and LVSD improves left ventricular function and cardiovascular outcome.
19. Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after percutaneous versus surgical coronary revascularization: is there a clear choice? Circulation 2002;106(suppl II):II-492.
20. Herzog CA. How to manage the renal patient with coronary heart disease: the agony and the ecstasy of opinion-based medicine. J Am Soc Nephrol 2003;14:2556-72. ▶ Excellent and extensive review of the management of CAD in patients with renal CKD.
21. Manske CL, Wilson RF, Wang Y, et al. Atherosclerotic vascular complications in diabetic transplant candidates. Am J Kidney Dis 1997;29:601-7.
22. American College of Cardiology, American Heart Association. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardiol 2007;50:159-241.